Stock Information
Repligen Corp (RGEN)
Ticker Symbol: RGEN
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $7,246.31 mil
Piotroski score: 5
PE Ratio: 135.7412
EPS (TTM): 0.8644
Revenue (TTM): $13.02 M
Dividend Yield: N/A%
ROE: 2.37%
Latest News
-
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
Fri, Mar 27, 2026 7:05 PM
-
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound?
Thu, Mar 26, 2026 3:30 PM
Key Financials
Financial data not available
